Vimarsana.com

Latest Breaking News On - Membrane type - Page 1 : vimarsana.com

Industrial Filtration Market worth $47.1 billion by 2029 - Exclusive Report by MarketsandMarkets

Industrial Filtration Market worth $47.1 billion by 2029 - Exclusive Report by MarketsandMarkets
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Northbrook
Illinois
United-states
Chicago
America
Asia-pacific
Stefan-klotter
Aashish-mehra
Industrial-filtration-companies
Power-market-research-reports-consulting
Research-insight
Linkedin

Deerfield Management Company L.P. Series C Buys New Position in Bicycle Therapeutics plc (NASDAQ:BCYC)

Deerfield Management Company L.P. Series C bought a new position in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 448,753 shares of the company’s stock, valued at approximately $9,015,000. Deerfield Management Company L.P. Series […]

Kevin-lee
Nigel-crockett
Morgan-stanley
Securities-exchange-commission
Canaccord-genuity-group
Td-asset-management-inc
Platinum-investment-management-ltd
Jump-financial
Deerfield-management-companylp-series
Cantor-fitzgerald
Investment-management
Needham-company

Deerfield Management Company L.P. Series C Invests $9.02 Million in Bicycle Therapeutics plc (NASDAQ:BCYC)

Deerfield Management Company L.P. Series C acquired a new stake in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 448,753 shares of the company’s stock, valued at approximately $9,015,000. Several other hedge funds have also recently added […]

Kevin-lee
Nigel-crockett
Fishman-jaya-ltd
Tower-research-capital
Maven-securities
Morgan-stanley
Canaccord-genuity-group
Securities-exchange-commission
Nasdaq
Needham-company
Deutsche-bank
Deerfield-management-companylp-series

Bicycle Therapeutics (NASDAQ:BCYC) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS

Bicycle Therapeutics (NASDAQ:BCYC) Posts Quarterly Earnings Results, Beats Estimates By $0.07 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Kevin-lee
Nigel-crockett
Securities-exchange-commission
Financial-group
Cantor-fitzgerald
Td-asset-management-inc
Platinum-investment-management-ltd
Jump-financial
Needham-company
Morgan-stanley
Bicycle-therapeutics-company-profile
Investment-management

Bicycle Therapeutics (NASDAQ:BCYC) Announces Quarterly Earnings Results, Beats Expectations By $0.07 EPS

Bicycle Therapeutics (NASDAQ:BCYC – Get Free Report) released its earnings results on Tuesday. The company reported ($1.16) earnings per share for the quarter, topping analysts’ consensus estimates of ($1.23) by $0.07, reports. The firm had revenue of $5.33 million during the quarter, compared to the consensus estimate of $11.68 million. Bicycle Therapeutics had a negative […]

China
Nigel-crockett
Kevin-lee
Cantor-fitzgerald
Bicycle-therapeutics-company-profile
Osaic-holdings-inc
Tower-research-capital
Canaccord-genuity-group
Bluepath-capital-management
Morgan-stanley
China-universal-asset-management-co
Bicycle-therapeutics

Bicycle Therapeutics plc to Post FY2025 Earnings of ($5.20) Per Share, Leerink Partnrs Forecasts (NASDAQ:BCYC)

Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) – Equities research analysts at Leerink Partnrs issued their FY2025 earnings per share estimates for Bicycle Therapeutics in a note issued to investors on Tuesday, February 20th. Leerink Partnrs analyst J. Chang forecasts that the company will earn ($5.20) per share for the year. The consensus estimate for […]

Nigel-crockett
Leerink-partnrs
Kevin-lee
Jpmorgan-chase-co
Morgan-stanley
Cantor-fitzgerald
Needham-company
Vident-investment-advisory
Nasdaq
Loomis-sayles-co
Bicycle-therapeutics
Free-report

Bicycle Therapeutics plc (NASDAQ:BCYC) Given Average Recommendation of "Moderate Buy" by Analysts

Bicycle Therapeutics plc (NASDAQ:BCYC) Given Average Recommendation of "Moderate Buy" by Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

China
Nigel-crockett
Kevin-lee
Cantor-fitzgerald
Morgan-stanley
Bluepath-capital-management
Osaic-holdings-inc
Nasdaq
Needham-company
Tower-research-capital
Securities-exchange-commission
China-universal-asset-management-co

Bicycle Therapeutics plc (NASDAQ:BCYC) Receives Average Rating of "Moderate Buy" from Brokerages

Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 […]

Nigel-crockett
Kevin-lee
Cantor-fitzgerald
Needham-company
Nasdaq
Armistice-capital
Morgan-stanley
Polar-capital-holdings-plc
Bicycle-therapeutics
Get-free-report
Capital-holdings-plc

Bicycle Therapeutics plc (NASDAQ:BCYC) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have been given an average rating of “Moderate Buy” by the seven brokerages that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 […]

Nigel-crockett
Kevin-lee
Needham-company
Nasdaq
Bluepath-capital-management
Morgan-stanley
Bicycle-therapeutics-company-profile
Tower-research-capital
Securities-exchange-commission
Cantor-fitzgerald
Osaic-holdings-inc

vimarsana © 2020. All Rights Reserved.